S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
NASDAQ:FLGT

Fulgent Genetics - FLGT Stock Forecast, Price & News

$36.21
-0.06 (-0.17%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$35.65
▼
$37.43
50-Day Range
$29.23
▼
$37.07
52-Week Range
$28.53
▼
$73.47
Volume
366,350 shs
Average Volume
194,178 shs
Market Capitalization
$1.07 billion
P/E Ratio
4.16
Dividend Yield
N/A
Price Target
$45.00

Fulgent Genetics MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
24.3% Upside
$45.00 Price Target
Short Interest
Bearish
6.29% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
1.30mentions of Fulgent Genetics in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$23,557 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From $4.93 to ($3.11) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Medical Sector

383rd out of 1,025 stocks

Medical Laboratories Industry

13th out of 25 stocks

See Top Rated MarketRank™ Stocks Here
FLGT stock logo

About Fulgent Genetics (NASDAQ:FLGT) Stock

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.

Receive FLGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter.

FLGT Stock News Headlines

January 31, 2023 | americanbankingnews.com
Fulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Update
January 3, 2023 | finance.yahoo.com
Fulgent Expands Board of Directors with Addition of Reggie Groves
February 5, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
December 23, 2022 | finance.yahoo.com
My Top 7 Strong Conviction Buys for 2023
December 8, 2022 | seekingalpha.com
At EV/Sales Below 1x, Fulgent Is Undervalued
December 8, 2022 | markets.businessinsider.com
Where Fulgent Genetics Stands With Analysts
December 5, 2022 | wsj.com
NASDAQ: FLGT Lawsuit Alert: Investors who lost Money with shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) should contact the Shareholders Foundation
December 2, 2022 | finance.yahoo.com
Owning 45% shares,institutional owners seem interested in Fulgent Genetics, Inc. (NASDAQ:FLGT),
February 5, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
November 28, 2022 | businesswire.com
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
November 24, 2022 | finance.yahoo.com
1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings
November 21, 2022 | benzinga.com
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
November 21, 2022 | benzinga.com
CLASS ACTION UPDATE for FLGT, PYPL and FRSH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
November 18, 2022 | benzinga.com
DEADLINE MONDAY NOTICE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
November 18, 2022 | technews.tmcnet.com
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
November 18, 2022 | benzinga.com
4 Analysts Have This to Say About Fulgent Genetics
November 18, 2022 | finance.yahoo.com
Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
November 17, 2022 | benzinga.com
4-Day Deadline Alert: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
November 16, 2022 | finance.yahoo.com
What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates
November 10, 2022 | benzinga.com
30.71M Reasons To Be Bullish On Fulgent Genetics Stock
November 10, 2022 | benzinga.com
Fulgent Genetics Chief Executive Officer Trades $30.71M In Company Stock
November 9, 2022 | benzinga.com
Fulgent Genetics's Investor Alert: Kaplan Fox Reminds Investors of an Important Deadline
November 9, 2022 | finance.yahoo.com
Fulgent Genetics Third Quarter 2022 Earnings: Beats Expectations
November 8, 2022 | apnews.com
Fulgent Genetics Reports Third Quarter 2022 Financial Results
November 8, 2022 | seekingalpha.com
Fulgent Genetics, Inc. (FLGT) Q3 2022 Earnings Call Transcript
November 8, 2022 | finance.yahoo.com
Fulgent Genetics, Inc. (FLGT) Beats Q3 Earnings and Revenue Estimates
November 4, 2022 | benzinga.com
CLASS ACTION UPDATE for MDT, FLGT and CMP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
See More Headlines
Receive FLGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter.

FLGT Company Calendar

Last Earnings
11/07/2022
Today
2/05/2023
Next Earnings (Estimated)
2/22/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FLGT
CUSIP
N/A
CIK
1674930
Web
www.fulgentgenetics.com
Phone
(626) 350-0537
Fax
626-454-1667
Employees
645
Year Founded
2011

Price Target and Rating

Average Stock Price Forecast
$45.00
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$40.00
Forecasted Upside/Downside
+24.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$8.70
Trailing P/E Ratio
4.16
Forward P/E Ratio
7.34
P/E Growth
N/A
Net Income
$507.36 million
Net Margins
33.82%
Pretax Margin
45.87%
Return on Equity
22.10%
Return on Assets
19.97%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.79
Quick Ratio
6.79

Sales & Book Value

Annual Sales
$992.58 million
Price / Sales
1.07
Cash Flow
$17.66 per share
Price / Cash Flow
2.05
Book Value
$39.08 per share
Price / Book
0.93

Miscellaneous

Outstanding Shares
29,440,000
Free Float
20,754,000
Market Cap
$1.07 billion
Optionable
Not Optionable
Beta
1.58

Social Links


Key Executives

  • Ming HsiehMing Hsieh
    Chairman & Chief Executive Officer
  • James Xie
    President & Chief Operating Officer
  • Paul H. KimPaul H. Kim
    Chief Financial Officer
  • Harry Gao
    Chief Scientific Officer & Laboratory Director
  • Lawrence M. Weiss
    Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













FLGT Stock - Frequently Asked Questions

Should I buy or sell Fulgent Genetics stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" FLGT shares.
View FLGT analyst ratings or view top-rated stocks.

What is Fulgent Genetics' stock price forecast for 2023?

3 analysts have issued twelve-month price targets for Fulgent Genetics' shares. Their FLGT share price forecasts range from $40.00 to $50.00. On average, they anticipate the company's stock price to reach $45.00 in the next year. This suggests a possible upside of 24.3% from the stock's current price.
View analysts price targets for FLGT or view top-rated stocks among Wall Street analysts.

How have FLGT shares performed in 2023?

Fulgent Genetics' stock was trading at $29.78 at the start of the year. Since then, FLGT shares have increased by 21.6% and is now trading at $36.21.
View the best growth stocks for 2023 here.

Are investors shorting Fulgent Genetics?

Fulgent Genetics saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 1,170,000 shares, an increase of 14.7% from the December 31st total of 1,020,000 shares. Based on an average daily volume of 274,400 shares, the days-to-cover ratio is presently 4.3 days. Currently, 6.3% of the company's stock are short sold.
View Fulgent Genetics' Short Interest.

When is Fulgent Genetics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our FLGT earnings forecast.

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics, Inc. (NASDAQ:FLGT) announced its quarterly earnings results on Monday, November, 7th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.13. The firm earned $105.66 million during the quarter, compared to the consensus estimate of $103.70 million. Fulgent Genetics had a net margin of 33.82% and a trailing twelve-month return on equity of 22.10%.

What guidance has Fulgent Genetics issued on next quarter's earnings?

Fulgent Genetics updated its fourth quarter 2022 earnings guidance on Monday, November, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $60.00 million-$60.00 million, compared to the consensus revenue estimate of $86.70 million.

What other stocks do shareholders of Fulgent Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Block (SQ), JD.com (JD), Marvell Technology (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT).

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,600,000 shares at $12.00-$14.00 per share. Credit Suisse and Piper Jaffray served as the underwriters for the IPO and Raymond James and BTIG were co-managers.

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

Who are Fulgent Genetics' major shareholders?

Fulgent Genetics' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Exchange Traded Concepts LLC (0.19%), SG Americas Securities LLC (0.16%), New York State Teachers Retirement System (0.09%), SummerHaven Investment Management LLC (0.05%), Yousif Capital Management LLC (0.04%) and Comerica Bank (0.04%). Insiders that own company stock include Hanlin Gao, Jian Xie, John C Bolger, Paul Kim and X Cycle LP Tcv.
View institutional ownership trends.

How do I buy shares of Fulgent Genetics?

Shares of FLGT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $36.21.

How much money does Fulgent Genetics make?

Fulgent Genetics (NASDAQ:FLGT) has a market capitalization of $1.07 billion and generates $992.58 million in revenue each year. The company earns $507.36 million in net income (profit) each year or $8.70 on an earnings per share basis.

How many employees does Fulgent Genetics have?

The company employs 645 workers across the globe.

Does Fulgent Genetics have any subsidiaries?
The following companies are subsidiares of Fulgent Genetics: CSI, Cytometry Specialists Inc., FF Gene Biotech, Fulgent Investment Development Limited, Fulgent Therapeutics LLC, and Inform Diagnostics.
Read More
How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The official website for the company is www.fulgentgenetics.com. The company can be reached via phone at (626) 350-0537, via email at nborsje@blueshirtgroup.com, or via fax at 626-454-1667.

This page (NASDAQ:FLGT) was last updated on 2/5/2023 by MarketBeat.com Staff